Giuseppe Mazza, Engitix CEO
Backed by billionaire Mike Platt, Engitix scores another deal with Takeda to go after IBD
Engitix is on a roll.
The British biotech backed by billionaire hedge fund manager Mike Platt secured an expansion on its earlier Takeda deal, it …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
